Form 4: Thermo Fisher Scientific Inc. Director Acquires Phantom Stock Units

Director Jennifer M. Johnson acquired phantom stock units in Thermo Fisher Scientific Inc. through the company's Deferred Compensation Plan for Directors.

Summary

• On March 29, 2025, Jennifer M. Johnson, a director of Thermo Fisher Scientific Inc., acquired phantom stock units.
• The acquisition was made through the Issuer's Deferred Compensation Plan for Directors.
• 62.48 phantom stock units were credited to Johnson's account at a price of $500.16 per unit.
• These units are convertible into common stock on a 1-for-1 basis and are distributable as stock upon cessation of director service or a change of control.
• Following the transaction, Johnson beneficially owns 397.51 derivative securities.

Sentiment

Score: 7

Explanation: The document is a standard regulatory filing detailing an insider transaction, which is neither particularly positive nor negative. The transaction itself is part of a compensation plan, suggesting a neutral sentiment.

Future Outlook

The shares are distributable as stock upon cessation of director service (for any reason) or a change of control.

Industry Context

This Form 4 filing is a routine disclosure related to insider transactions and is a common practice for publicly traded companies. It provides transparency into the holdings and transactions of company insiders.

Key Dates

Keywords

Thermo Fisher Scientific, Director, Phantom Stock Units, Deferred Compensation Plan, Beneficial Ownership, Form 4, TMO